Pete Garcia

Pete Garcia has extensive experience in finance and corporate governance, serving in key roles such as Chief Financial Officer at ALX Oncology and PDL BioPharma, as well as holding positions on the Board of Directors for companies including DURECT Corporation, Moraga Biotechnology Corporation, and Noden DAC. Pete Garcia holds an MBA in Finance from UCLA Anderson School of Management and a BA in Economics from Stanford University.